Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance Published 05 Aug 2022 Full Article
Paya Holding; Non-GAAP EPS of $0.10 beats by $0.01, revenue of $72.5M beats by $2.68M;revises FY guidance SeekingAlpha 05 Aug 2022
Kiniksa Pharmaceuticals GAAP EPS of -$0.29 beats by $0.15, revenue of $26.97M misses by $1.58M, reaffirms FY revenue guidance SeekingAlpha 03 Aug 2022